Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614).
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614). Blood Adv. 2019 06 11; 3(11):1714-1721.